Evidence map›Paper›PMID 36222077›Full record

Observational studyPediatric obesity2023

Short-term complications and post-acute sequelae in hospitalized paediatric patients with COVID-19 and obesity: A multicenter cohort study.

Gonzalo Valenzuela, Gonzalo Alarcón-Andrade, Clara Schulze-Schiapacasse, Rocío Rodríguez, Tamara García-Salum, Catalina Pardo-Roa, Jorge Levican, Eileen Serrano, María José Avendaño, Monserrat Gutiérrez and 21 more

Open access · greenAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Pediatric obesity, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 1 institution in 2 countries.

Gonzalo ValenzuelaDepartment of Pediatric Infectious Diseases and Immunology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.ORCID 0000-0002-5538-8749
Gonzalo Alarcón-AndradeDepartment of Pediatric Infectious Diseases and Immunology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.ORCID 0000-0001-8139-7027
Clara Schulze-SchiapacasseDepartment of Pediatric Infectious Diseases and Immunology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.ORCID 0000-0003-1010-8755
Rocío RodríguezDivision of Pediatrics, Pontificia Universidad Católica de Chile, Hospital Clínico Red Salud UC-Christus, Santiago, Chile.
Tamara García-SalumDepartment of Pediatric Infectious Diseases and Immunology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.ORCID 0000-0002-0170-9965
Catalina Pardo-RoaDepartment of Pediatric Infectious Diseases and Immunology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
Jorge LevicanDepartment of Pediatric Infectious Diseases and Immunology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
Eileen SerranoDepartment of Pediatric Infectious Diseases and Immunology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
María José AvendañoDepartment of Pediatric Infectious Diseases and Immunology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
Monserrat GutiérrezDepartment of Pediatrics, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
Loreto GodoyDepartment of Pediatrics, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
Pamela CéspedesDivision of Pediatrics, Pontificia Universidad Católica de Chile, Hospital Dr. Sótero del Río, Santiago, Chile.
Sandra BermudezDivision of Pediatrics, Pontificia Universidad Católica de Chile, Hospital Dr. Sótero del Río, Santiago, Chile.
Javiera AravenaDepartment of Pediatrics, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
Irini NicolaidesDepartment of Pediatrics, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
Eliana MartínezDepartment of Pediatrics, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
Constanza Gómez-CanobbioDepartment of Pediatrics, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
Macarena JofréDepartment of Pediatrics, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
Andrea SalinasDepartment of Pediatrics, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
Daniela DepaoliCentro de Responsabilidad de Peditaría, Hospital Clínico La Florida, Santiago, Chile.
Carolina LozaDepartment of Pediatrics, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
Andrés MuñozDepartment of Pediatrics, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
Natalia OrmazábalCentro de Responsabilidad de Peditaría, Hospital Clínico La Florida, Santiago, Chile.
Diana ManzurDivision of Pediatrics, Pontificia Universidad Católica de Chile, Hospital Clínico Red Salud UC-Christus, Santiago, Chile.
José BarrigaDivision of Pediatrics, Pontificia Universidad Católica de Chile, Hospital Clínico Red Salud UC-Christus, Santiago, Chile.
Leonardo I AlmonacidDepartment of Pediatric Infectious Diseases and Immunology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
Estefany Poblete-CárdenasDepartment of Pediatric Infectious Diseases and Immunology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
Erick SalinasDepartment of Pediatric Infectious Diseases and Immunology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
Andrés Muñoz-MarcosDepartment of Pediatric Infectious Diseases and Immunology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
Salesa BarjaDepartment of Pediatrics, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
Rafael A MedinaDepartment of Pediatric Infectious Diseases and Immunology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.ORCID 0000-0002-5013-6884
Pontificia Universidad Católica de Chile · CL

Funding

SARS-CoV adaptations through a Systems Biology Lens (SYBIL)U19AI135972 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Adolfo Garcia-Sastre · 2018 to 2026
$27.2M
NIAID NIH HHS HHSN272201400008CNIAID NIH HHS U19 AI135972
6 · The paper itself

Abstract

backgroundObesity increases the severity of coronavirus disease 2019 illness in adults. The role of obesity in short-term complications and post-acute sequelae in children is not well defined.

objectiveTo evaluate the relationship between obesity and short-term complications and post-acute sequelae of SARS-CoV-2 infection in hospitalized paediatric patients.

methodsAn observational study was conducted in three tertiary hospitals, including paediatric hospitalized patients with a confirmatory SARS-CoV-2 RT-PCR from March 2020 to December 2021. Obesity was defined according to WHO 2006 (0-2 years) and CDC 2000 (2-20 years) growth references. Short-term outcomes were intensive care unit admission, ventilatory support, superinfections, acute kidney injury, and mortality. Neurological, respiratory, and cardiological symptoms and/or delayed or long-term complications beyond 4 weeks from the onset of symptoms were considered as post-acute sequalae. Adjusted linear, logistic regression and generalized estimating equations models were performed.

resultsA total of 216 individuals were included, and 67 (31.02%) of them had obesity. Obesity was associated with intensive care unit admission (aOR = 5.63, CI95% 2.90-10.94), oxygen requirement (aOR = 2.77, CI95% 1.36-5.63), non-invasive ventilatory support (aOR = 6.81, CI95% 2.11-22.04), overall superinfections (aOR = 3.02 CI95% 1.45-6.31), and suspected bacterial pneumonia (aOR = 3.00 CI95% 1.44-6.23). For post-acute sequalae, obesity was associated with dyspnea (aOR = 9.91 CI95% 1.92-51.10) and muscle weakness (aOR = 20.04 CI95% 2.50-160.65).

conclusionsIn paediatric hospitalized patients with COVID-19, severe short-term outcomes and post-acute sequelae are associated with obesity. Recognizing obesity as a key comorbidity is essential to develop targeted strategies for prevention of COVID-19 complications in children.

Indexed as

COVID-19SuperinfectionAdultChildCohort StudiesHumansObesityPost-Acute COVID-19 SyndromeRetrospective StudiesSARS-CoV-2adolescentchildCOVID-19intensive care unitsobesitypost-acute COVID-19 syndrome

Identifiers

PMID36222077
PMCPMC9874399
OpenAlexW4304758525

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.